These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 27138074

  • 1. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S, Kanetaka H, Hirao K, Fukasawa R, Namioka N, Hatanaka H, Hirose D, Umahara T, Sakurai H, Hanyu H.
    Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
    [Abstract] [Full Text] [Related]

  • 2. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S, Hirao K, Kanetaka H, Namioka N, Hatanaka H, Hirose D, Fukasawa R, Umahara T, Sakurai H, Hanyu H.
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and 123 I-metaiodobenzylguanidine myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
    Kobayashi S, Makino K, Hatakeyama S, Ishii T, Tateno M, Iwamoto T, Tsujino H, Kawasaki K, Mikuni K, Ukai W, Murayama T, Hashimoto E, Utsumi K, Kawanishi C.
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [Abstract] [Full Text] [Related]

  • 5. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C, SCILLA Working Group.
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
    McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C, DLB Study Group.
    Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
    [Abstract] [Full Text] [Related]

  • 7. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D, Aarsland D, McKeith IG.
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [Abstract] [Full Text] [Related]

  • 8. [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies.
    Walker Z, Cummings JL.
    Alzheimers Dement; 2012 Jan; 8(1):74-83. PubMed ID: 22024052
    [Abstract] [Full Text] [Related]

  • 9. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H, Shimizu S, Hirao K, Kanetaka H, Iwamoto T, Chikamori T, Usui Y, Yamashina A, Koizumi K, Abe K.
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
    [Abstract] [Full Text] [Related]

  • 10. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ, Firbank MJ, Pakrasi S, Lloyd JJ, Driver I, McKeith IG, Williams ED, O'Brien JT.
    Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J, Morgan S, Bradley KM, Noel-Storr AH, Ansorge O, Hyde C.
    Cochrane Database Syst Rev; 2015 Jan 30; 1(1):CD010633. PubMed ID: 25632881
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.
    Kamagata K, Nakatsuka T, Sakakibara R, Tsuyusaki Y, Takamura T, Sato K, Suzuki M, Hori M, Kumamaru KK, Inaoka T, Aoki S, Terada H.
    Neuroradiology; 2017 Jan 30; 59(1):89-98. PubMed ID: 28035426
    [Abstract] [Full Text] [Related]

  • 14. The value of multimodal imaging with 123I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia.
    Miyagawa T, Przybelski SA, Maltais D, Min HK, Jordan L, Lesnick TG, Chen Q, Graff-Radford J, Jones D, Savica R, Knopman D, Petersen R, Kremers WK, Forsberg LK, Fields JA, Ferman TJ, Allen L, Parisi J, Reichard RR, Murray M, Dickson D, Boeve BF, Kantarci K, Lowe VJ.
    Neurobiol Aging; 2021 Mar 30; 99():11-18. PubMed ID: 33422890
    [Abstract] [Full Text] [Related]

  • 15. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S, Kemp P, Booij J, Costa DC, Padayachee S, Lee L, Barber C, Carter J, Walker Z.
    J Neurol Neurosurg Psychiatry; 2012 Nov 30; 83(11):1063-70. PubMed ID: 22869921
    [Abstract] [Full Text] [Related]

  • 16. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
    Walker Z, Jaros E, Walker RW, Lee L, Costa DC, Livingston G, Ince PG, Perry R, McKeith I, Katona CL.
    J Neurol Neurosurg Psychiatry; 2007 Nov 30; 78(11):1176-81. PubMed ID: 17353255
    [Abstract] [Full Text] [Related]

  • 17. Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies.
    Inagawa Y, Inagawa S, Takenoshita N, Yamamoto R, Tsugawa A, Yoshimura M, Saito K, Shimizu S.
    PLoS One; 2024 Nov 30; 19(9):e0309885. PubMed ID: 39250493
    [Abstract] [Full Text] [Related]

  • 18. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study.
    van der Zande JJ, Joling M, Happach IG, Vriend C, Scheltens P, Booij J, Lemstra AW.
    Neuroimage Clin; 2020 Nov 30; 25():102062. PubMed ID: 31790878
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.
    Hanyu H, Shimizu S, Hirao K, Kanetaka H, Sakurai H, Iwamoto T, Koizumi K, Abe K.
    J Neurol Sci; 2006 Dec 01; 250(1-2):97-102. PubMed ID: 17005204
    [Abstract] [Full Text] [Related]

  • 20. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.
    Pasquier J, Michel BF, Brenot-Rossi I, Hassan-Sebbag N, Sauvan R, Gastaut JL.
    Eur J Nucl Med Mol Imaging; 2002 Oct 01; 29(10):1342-8. PubMed ID: 12271417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.